• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.56% Nasdaq Down0.79%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    5.21 Down 0.43(7.62%) May 4, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 13,680   10,825   7,000  
    Cost of Revenue6,644  495   -  
    Gross Profit 7,036   10,330   7,000  
    Operating Expenses
    Research Development36,694  51,502  34,734  
    Selling General and Administrative81,410  70,057  19,349  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (111,068) (111,229) (47,083)
    Income from Continuing Operations
    Total Other Income/Expenses Net(11,987)411  351  
    Earnings Before Interest And Taxes(123,055)(110,818)(46,732)
    Interest Expense -   -   -  
    Income Before Tax(123,055)(110,818)(46,732)
    Income Tax Expense90  700   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(123,145)(111,518)(46,732)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (123,145) (111,518) (46,732)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (123,145) (111,518) (46,732)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.